Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy
High-affinity IL-2Rα expressed by Tregs mitigates the potential of IL-2 use in cancer therapy. Here, the authors fuse IL-2 with an NKDG2 binding domain, and show that it induces IL-2 signalling selectively in NKG2D+cells, delaying tumour growth in mice without the side effects of conventional IL-2 t...
Guardado en:
Autores principales: | Reza Ghasemi, Eric Lazear, Xiaoli Wang, Saeed Arefanian, Alexander Zheleznyak, Beatriz M. Carreno, Ryuji Higashikubo, Andrew E. Gelman, Daniel Kreisel, Daved H. Fremont, Alexander Sasha Krupnick |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/556e5f18a8074910ad3823823e1bf265 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus
por: Di Yang, et al.
Publicado: (2017) -
NKG2A is a NK cell exhaustion checkpoint for HCV persistence
por: Chao Zhang, et al.
Publicado: (2019) -
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma
por: Sam Sheppard, et al.
Publicado: (2017) -
INHIBITION OF THE NKG2D ACTIVATING RECEPTOR EXPRESSION ON CYTOTOXIC LYMPHOCYTES BY RECOMBINANT MICA PROTEIN
por: E. V. Abakushina, et al.
Publicado: (2017) -
NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection
por: Yadong Wang, et al.
Publicado: (2017)